Immortalized, interleukin-3 (I-3)-dependent mouse mast cells (PB-3c) were transfected with a human activated c-H-ras gene under the transcriptional control of the mouse mammary tumor virus long terminal repeat. Addition of increasing amounts of dexamethasone resulted in a concentration-dependent increase in expression of the H-ras oncogene. The elevation of p21 ras protein concentrations was paralleled by progressive growth of the transfectants in the absence of exogenous IL-3, leading to complete abrogation of growth-factor requirement at high p2l1 levels. The maintenance of the IL-3-independent state required the continuous expression of the H-ras oncogene, since dexamethasone removal was followed by rapid cell death. Expression of the H-ras oncogene induced PB-3c cells to produce IL-3 and granulocyte-macrophage colony-stimulating factor, suggesting that their IL-3-independent proliferation may be due to an autocrine mechanism.
Introduction
There is growing evidence that proto-oncogenes are involved in the regulation of normal cell growth and differentiation and that alterations of these genes lead to the development of cancer (see Weinberg, 1985; Bishop, 1987 , for reviews). A frequent feature of transformed cells is their partial or complete autonomy from growth factor requirements that regulate the proliferation of their non-transformed counterparts. Growth factor independence of transformed cells has been postulated to be due to constitutive activation of any of the elements of the signal transduction pathway-the growth factor itself, its membrane receptor or components of the intracellular signaling system (Heldin and Westermark, 1984) .
Proliferation of hematopoietic cells is regulated by a series of well-characterized growth factors, and it has been suggested that leukemogenesis may involve disturbances in this hormonal control. The dependence of hematopoietic cell lines on specific growth factors makes them useful to investigate the potential role of an oncogene in a signal transduction pathway. Some work has been carried out with cells that are dependent on interleukin-3 (IL-3) for survival and growth. This growth factor, a product of activated T cells, induces the proliferation and supports the differentiation of many hematopoietic cell lineages and stimulates ©IRL Press the self-renewal and development of multipotent stem cells (for review, see Whetton and Dexter, 1986) .
The signaling transduction pathway triggered by IL-3 has not yet been elucidated but seems to involve tryosine phosphorylation of cellular targets (Koyasu et al., 1987 ; Morla et al., 1988) after binding of the hormone to its receptor (Park et al., 1986; Isfort et al., 1988) . The finding that transfection with oncogenes encoding tyrosine protein kinases such as v-abl (Cook et al., 1985; Pierce et al., 1985; Mathey-Prevot et al., 1986) , v-src (Watson et al., 1987) or v-fins (Wheeler et al., 1987) leads to abrogation of IL-3 dependence, supports the hypothesis that IL-3 transmits its signal via a cellular tyrosine protein kinase.
A few studies have addressed the relationship between ras oncogene expression and IL-3 requirement. Infection of primary mast cells with Harvey sarcoma virus does not render them independent of exogenous IL-3 but extends their survival time in vitro (Rein et al., 1985) . However, we have recently shown that introduction of the v-H-ras gene into the mouse mastocyte line PB-3c (Ball et al., 1983; Conscience and Fischer, 1985) leads to a 10-to 20-fold reduction in their IL-3 requirement (Nair et al., 1989) . A second complementing event can then generate growth autonomy in these cells by autocrine IL-3 production. To investigate its role in reducing the IL-3 requirement and its function in establishing the autocrine loop, we have made use of an inducible ras oncogene which allows the modulation of p21 ras protein levels within the cells. We show that low levels of p21 ras reduce the IL-3 requirement, whereas high p2lras levels induce a reversible state of IL-3 independence. Expression of the ras oncogene is accompanied by the production of IL-3 and granulocytemacrophage colony-stimulating factor (GM-CSF).
Results
Transfection of IL-3-dependent PB-3c cells with a hormone-inducible H-ras oncogene PB-3c cells were co-electroporated with the human activated c-H-ras gene from the T24 bladder carcinoma cell line under the transcriptional control of the MMTV LTR (Jaggi et al., 1986) together with DNA carrying the dominant selectable neo gene [pZip neo SV(X)] (Cepko et al., 1984) . Control cells were electroporated with the neo-carrying plasmid alone. Both cultures were then selected for resistance to the neomycin antibiotic G418 in the presence of IL-3. In parallel, we subcloned the cells in methylcellulose containing IL-3 and G418 48 h after electroporation. Southern blot analysis of neomycin-resistant cells revealed integration of the MMTV LTR H-ras construct (data not shown). Using immunoprecipitation, a dexamethasone-induced increase in p21ros expression was observed in the transfected mass culture (Figure 1 ). From seven cell clones analyzed (see below) three were similarly tested by immunoprecipitation control mass culture -259 (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17 and 19) or control rat immunoglobulin (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20) . The cells were labeled in the absence (lanes, 1, 2, 5, 6, 9, 10, 13, 14, 17 and 18) or presence (lanes 3, 4, 7, 8, 11, 12, 15, 16, 19 and 3, 5, 7, 9, 11, 13 and 15) or control rat immunoglobulin (lanes 2, 4, 6, 8, 10, 12, 14 and 16) . (B) 2C1 cells (5 x 104 cells/ml) were cultured in IL-3-free medium in the absence (X) or presence of [10-10 M (0), 10-9 M (A), 5 x i0-9 M (o), 1o-8 M (A), 10-7 M (0), 10-6 M (0)] dexamethasone. Growth of V2 cells in IL-3-free medium is indicated by ( O). neo-transfected cells treated with or without 10-6 M dexamethasone were included as controls (fl). The number of viable cells was determined by the ability to exclude trypan blue. Fig. 2 . IL-3-independent growth of MMTV LTR H-ras-transfected cells in the presence of dexamethasone. Growth curves were established for PB-3c cells tranfected with neo (A), PB-3c cells co-transfected with neo and MMTV LTR H-ras (B), and co-tranfected cell clones 2B6 (C) and 2C1 (D). Cells were seeded at 5 x 104 cells/mi in medium containing saturating amounts of IL-3 either in the absence (A) or presence (A) of 10-6 M dexamethasone. Growth in factor-free medium was also examined either in the absence (0) or presence (0) of 10-6 M dexamethasone. The values represent total cell numbers. and were shown to express p2lras in response to dexamethasone treatment. No p2lras was detected in PB-3c control cells, whereas the transfected cultures had low levels of p2lr' even in the absence of dexamethasone, indicating low constitutive expression of the MMTV LTR H-ras construct. To evaluate the effects of H-ras oncogene expression on IL-3 dependency, transfectants were cultured in medium with or without IL-3 in the presence or absence of dexamethasone. As shown in Figure 2A , the neotransfected PB-3c mass culture did not grow in the absence of exogenous IL-3 with or without dexamethasone, and thus behaved like untransfected PB-3c cells (not shown). A slight inhibition of growth was noted when dexamethasone was present in addition to IL-3 (Figure 2A , compare closed and open triangles). The co-transfected culture, however, grew in factor-free medium if dexamethasone was present ( Figure  2B , compare closed and open circles) and could be propagated in IL-3-free medium indefinitely. The viability of these cells remained >70% during the course of the experiment, indicating that abrogation of the IL-3 requirement occurred in the majority of co-transfected cells. Growth analysis of two clones gave similar results ( Figure  2C ,D): as in the co-transfected mass culture, the presence of the steroid-hormone allowed the cells to grow in IL-3-free medium. In all cases, slightly higher growth rates and saturation densities were reached when IL-3 was present in the medium. The IL-3-independent state remained a stable feature of these cells provided dexamethasone was present (see below).
Effect of p2lias levels on IL-3 requirement Abrogation of IL-3-dependence was unexpected in view of our earlier finding that v-H-ras expression in PB-3c cells reduced, but did not abrogate IL-3 requirement (Nair et al.,
1989).
To test the possibility that a difference in amount of p21r' could account for the different effects, we compared the p2lr' levels in the v-H-ras-expressing cell line, V2, with those in cells transfected with MMTV LTR H-ras. We chose the cell clone 2C 1 which showed an efficient induction of H-ras expression and abrogation of IL-3 requirement in response to dexamethasone stimulation and low constitutive p2lrL' levels (Figures 1 and 2D ). Immunoprecipitations carried out on labeled 2C1 cells showed that the levels of p2lras could be increased as a function of the concentration of the inducer ( Figure 3A ). Maximal induction of the ras protein was seen at 10-6 M dexamethasone. The relative levels of p2 lras expression were quantitated by densitometric scanning analysis and were found to be 20-fold lower in the V2 line than in the maximally induced 2C1 cells. In fact, they corresponded to levels in 2C1 cells induced with -10-9 M dexamethasone. It was now of interest to see how varying amounts of p2lras affected the growth potential and survival of 2C1 cells in IL-3-free medium. Accordingly, 2C1 cells were washed and tested for IL-3-independent growth in response to increasing concentrations of dexamethasone. We observed that increasing the amount of the inducer led to progressive factor-independent growth ( Figure 3B ). At low dexamethasone concentrations, transfected cells responded with prolonged survival but little or no proliferation in factorfree medium. At intermediate p2lraS levels (10-9 to 5 x 10-9 M dexamethasone), there was abortive proliferation followed by eventual cell death. Above the threshold level of p21r(s (5 x 10-9 M dexamethasone), the cells responded with factor-independent growth. In contrast, control cells died within 24 h with or without dexamethasone. Survival of V2 cells in IL-3-free medium was comparable to 2C1 cells in the absence of dexamethasone ( Figure 3B ).
Reversibility of H-ras-dependent abrogation of IL-3 dependence
To examine whether the IL-3-independent growth induced by dexamethasone was reversible, cells of clones 2B6 and 2C1 were washed and replated in medium without dexamethasone after growth in IL-3-free medium in the presence of dexamethasone for 4 months. We found that the factorindependent state was completely reversible. The cells died after removal of dexamethasone, but grew when replated in the presence of dexamethasone or IL-3 ( Figure 4 ).
Accumulation of IL-3 mRNA and GM-CSF mRNA in transfected cells
A sensitive RNase protection assay (Melton et al., 1984) was used to examine if the abrogation of IL-3-dependence was correlated with the production of IL-3. A single-stranded radioactive SP6 RNA probe complementary to 368 nucleotides of the IL-3 cDNA was hybridized to RNA derived from a co-transfected mass culture or from neo-transfected control cells. Figure 5A shows that a faint band of a protected RNA fragment of the expected size of 368 nucleotides is detectable in H-ras-transfected cells (lane 12). Actual induction of IL-3 mRNA in these cells was observed after dexamethasone infected PB-3c cells do not induce IL-3 mRNA (Nair et al., 1989) , indicate that expression of the IL-3 gene requires relatively high levels of p21ras. We also analyzed the expression of the GM-CSF gene, as co-regulation of this gene with the IL-3 gene has frequently been observed. Hybridization of RNA samples with a 32P-labeled SP6-GM-CSF probe revealed a protected 400-bp-long fragment in Hras transfected cells (Figure SA, lane 5), whereas PB-3c control cells did not show expression of the lymphokine (Figure SA, lanes 3 and 4) . However, the accumulation of the GM-CSF mRNA in the ras transfectants could not be increased significantly by treatment of the cells with dexamethasone for 24 h, either in the absence ( Figure 5A Apparently, the low levels of p21ras expression due to the leakiness of the MMTV LTR H-ras construct are sufficient for GM-CSF induction and enhanced expression of ras does not augment GM-CSF mRNA levels further.
Evidence for clonal variation was obtained when two cell clones were similarly subjected to RNase protection analysis. While both clones were shown to express GM-CSF ( Figure  SB, lanes 5-8) , clone 2C1 did not express the IL-3 gene ( Figure SB, lane 14) . Apparently IL-3-independent growth can occur without autocrine IL-3 stimulation. It is noteworthy that the IL-3-expressing clone 2B6 showed higher levels of p21ras than clone 2C1 (see Figure 1 ). The faint GM-CSF band detected in control cells ( Figure SB, lane 4) was not consistently detected in repeat experiments.
Production of IL-3 and GM-CSFin hormone-induced MMTV-LTR H-ras-transfected PB-3c cells Supernatants from several induced cell lines growing in IL-3-free medium were assayed for mitogenicity on FDC-P1 cells, which are dependent on either IL-3 or GM-CSF for growth. Figure 6 shows that all the media contained a mitogenic activity that could support the growth of FDC-P1 cells. Pre-incubation of these supernatants with anti-GM- CSF antibody inhibited their activity to various degrees, indicating that all of the transfected cells secreted GM-CSF and probably (an) additional factor(s). The conditioned media were also assayed on PB-3c, which are strictly dependent on IL-3 and do not respond to GM-CSF. The mass culture contained low but significant activity and the clones showed strong variation in their ability to stimulate PB-3c cells (Table   I ). Clone 2C1 for example, in agreement with the RNase protection data, was negative. These differences do not seem to reflect the levels of p21r' expression, as a comparison between cell clones 2A3 and 2B6 shows that although these cells express similar levels of p2lr'S (see Figure 1 ) they differ in their ability to support the growth of PB-3c cells (Table I ). Some transfectants, e.g. 2C2, showed a higher mitogenic activity on PB-3c cells than would be expected from the residual activity obtained with FDC-P1 cells in the presence of anti-GM-CSF antibody (see Figure 6 ). This could be explained by the fact that the supernatant from 2C2, a very high producer, had to be diluted in order to obtain the desired amount of activity suitable for the antibody experiment (see legend to Figure 6 ).
Discussion
Abrogation of IL-3 requirement for the proliferation of factor-dependent cells has up to now been reported principally for oncogenes of the tyrosine protein kinase family (Cook et al., 1985; Pierce et al., 1985;  Mathey- Prevot et al., 1986; Watson et al., 1987; Wheeler et al., 1987) and by the c-src activating polyma middle-T antigen (Metcalf et al., 1987) . The abrogation of IL-3 dependence by the non-tyrosine kinase-encoding oncogene v-myc (Rapp et al., 1985) may require an additional selective event (Cory et al., 1987; Hume et al., 1988) . In this report we provide evidence for the direct involvement of another non-tyrosine kinase-encoding oncogene in abrogation of IL-3 requirement. The use of the MMTV LTR H-ras gene construct allowed us to demonstrate that the effects of the ras oncogene are dosage dependent. We could distinguish three phenotypes Fifty-fold concentrated media conditioned by the indicated dexamethasone-induced cells were tested for mitogenic activity on PB-3c cells. An antiserum directed against IL-3 verified the specificity of the mitogenic effect, as shown with the supematant from clone 2B6.
aAfter pre-incubation with control rabbit immunoglobulin.
bAfter pre-incubation with anti-IL-3 antibody.
1989) is most likely explained by the 20-fold lower levels of p2lrcn expression in v-H-ras-infected cells compared to the levels in maximally induced cells tranfected with MMTV LTR H-ras. Recently, it has been demonstrated that the activated human H-ras oncogene contains, in addition to the activating mutation at codon 12, a point mutation in the fourth intron that causes a 10-fold increase in gene expression and enhances transformation (Cohen and Levinson, 1988 ). It will be interesting to see whether this intron mutation which is also present in the MMTV LTR H-ras construct is critical for the abrogation mechanism. Evidence that quantitative changes in ras gene expression are important in cell transformation has also come from work with fibroblasts showing that the levels of p2lr'n correlate with the extent of morphological transformation and the degree of DNA synthesis (McKay et al., 1986; Reynolds et al., 1987) . In addition, when the mutated H-ras gene is expressed at high levels, it does not require a co-operating gene to induce stable transformation of primary cells (Spandidos and Wilkie, 1984; Land et al., 1986) . These data are similar to our findings in PB-3c cells where abrogation of IL-3 dependence can be accomplished either by low levels of v-H-ras expression complemented by a second event (Nair et al., 1989) , or directly by expression of high levels of the activated H-ras gene as shown here.
We have demonstrated that the continuous expression of a functional H-ras oncogene is required for the maintenance of IL-3 independence in PB-3c cells, as removal of dexamethasone resulted in rapid cell death, even after growth of the cells in the presence of the hormone for >4 months.
This supports the conclusion that IL-3 independence is direcfly induced by high levels of p2lr'S and does not require an additional selective event. A similar situation has been described using a temperature-sensitive mutant of v-abl, where the IL-3 abrogation mechanism was also reversible and required the continuous expression of the viral protein (Kipreos and Wang, 1988) .
At least two models could account for the H-ras-induced release of IL-3-dependence in PB-3c cells. First, the p2lrcI protein might interact with or substitute for proteins that function in the IL-3 signal transduction pathway. Since ras proteins bind and hydrolyze GTP (Gibbs et al., 1984; Sweet et al., 1984) and have sequence homology to G-proteins (Hurley et al., 1984) , it is thought that they are involved in the transduction of signals across cell membranes. If the IL-3 signal transduction pathway involves a G-protein, this could provide a site of action for the ras protein. The second possibility is based on the observations that ras oncogenes can induce gene expression at the transcriptional level (Wasylyk et al., 1987) and that ras-transformed cells often produce growth factors such as type oa or (3 transforming growth factors (De Larco and Todaro, 1978; Anzano et al., 1985) and platelet-derived growth factor (Bowen-Pope et al., 1984) . Our finding that H-ras-expressing PB-3c cells produce IL-3 and GM-CSF suggests that expression of these lymphokines may be similarly regulated. The mechanism of GM-CSF mRNA and IL-3 mRNA accumulation, however, remains to be investigated, particularly in view of the finding that GM-CSF mRNA expression can be regulated at the post-transcriptional level (Shaw and Kamen, 1986; Schuler and Cole 1988) .
PB-3c cells can be rendered IL-3 independent following the establishment of an autocrine IL-3 loop by IL-3 gene rearrangement (Nair et al., 1989) or by IL-3 cDNA transfection (unpublished results with A.Wodnar-Filipowicz and W.Ostertag). Thus, the correlation of IL-3 independence with high levels of p2l' expression and IL-3 production suggests that the autonomous growth of PB-3c cells may be due to a ras-induced autocrine mechanism. The observation, however, that some cell clones exhibit growth autonomy without production of detectable levels of IL-3 indicates that ras-induced IL-3 production is not the only mechanism to accomplish abrogation of IL-3 requirement. It appears that p2lras expression renders these cells IL-3 independent by an unknown non-autocrine mechanism. This view is supported by data obtained from cloning of 2C1 cells in methylcellulose, where colony numbers increased linearly with the numbers of cells plated and potent antisera directed against GM-CSF and IL-3 did not inhibit proliferation of these cells (data not shown). The availability of IL-3-producing and non-producing autonomous cell clones offers the opportunity to investigate the underlying mechanisms for the release of IL-3 requirement in more detail.
Materials and methods
Cell culture Cell lines include PB-3c, a cloned, IL-3-dependent mast cell line isolated from mouse bone marrow (Ball et al., 1983; Conscience and Fischer, 1985) , FDC-Pl, a murine hematopoietic cell line dependent on either GM-CSF or IL-3 (Dexter et al., 1980) , WEHI-3B (D-subline), a mouse myelomonocytic leukemia cell line that secretes IL-3 (Lee et al., 1982) , and DIND4, a factor-independent mutant of the mouse granulocytemacrophage precursor cell line D35 (Stocking et al., 1988) . V2 is a cell line derived form an infection of PB-3c cells with a recombinant retrovirus carrying the v-H-ras gene (Nair et al., 1989) . The cells were cultured in Iscove's modified Dulbecco's medium (IMDM) supplemented with penicillin (100 U/ml), streptomycin (100 tg/ml), ,B-mercaptoethanol (50 ftM) and 10% fetal calf serum. IL-3-dependent cell lines were grown in the presence of optimal mitogenic concentrations of WEHI-3 cell conditioned medium (WEHI-3 CM).
Electroporation PB-3c cells were suspended in cold phosphate-buffered saline (PBS) at a concentration of 4 x 107 cells/mi. Zip neo SV (X) plasmid DNA linearized with the SaII restriction endonuclease was added to the cell suspension to 20 1tg/ml. In co-electroporation experiments, Sall-linearized MMTV LTR H-ras plasmid DNA was added to a final concentration of 100 tg/ml. The DNA cell suspension was subjected to an electric pulse (960 1tF, 300 V) delivered by a BioRad Gene PulserTM. After electroporation, the cells were kept on ice for 15 min, followed by a 15-min incubation at room temperature. The cells were then transferred to culture medium and grown for 48 h before transfectants were selected in medium supplemented with G418 (1 mg/ml).
Cloning in methylcellulose
Cloning in methylcellulose was carried out according to Davis et al. (1982) . Briefly, 106 cells were plated in 35-mm tissue culture dishes containing ml methylcellulose culture mixture. This consisted of 1.2% (w/v) methylcellulose in IMDM, supplemented with 1% bovine serum albumin, 20% fetal calf serum, 300 Ag/ml iron-saturated human transferrin, 2 mg/ml G418, 2 mM L-glutamine and saturating amounts of WEHI-3 CM.
Macroscopic colonies were picked -10 days later and were expanded in suspension cultures containing 1 mg/ml G418 and WEHI-3 CM. Immunoprecipitation Cells (106) were labeled with [35S]methionine (100 isCi/dish; Amersham) for 17 h in 2ml of IMDM lacking methionine and containing 10% dialyzed fetal calf serum and WEHI-3 CM. Dexamethasone was added where indicated. Cells were washed twice in PBS and lysed in 1 ml of 50 mM Tris-HCI buffer (pH 8.0) containing 120 mM NaCl, 1% Triton X-100 and 1% aproptinin. Cell extracts were pre-cleared by incubation with 50,1l
Pansorbin (Calbiochem) for 10 min on ice, and centrifuged at 13 000 r.p.m.
for 5 min in an Eppendorf centrifuge. Then 2 x 106 c.p.m. of trichloroacetic acid-precipitable radioactive material was incubated with the rat anti-rasp21 monoclonal antibody Y13-259 (Furth et al., 1982) or with normal rat serum for 40 min on ice. Fifty microliters of Protein A-Sepharose-4B coated with rabbit anti-rat IgG (Nordic) was added for another 2 h on ice. Precipitates were washed sequentially with the following buffers: (i) 1% Triton X-100, 0.5% Na-deoxycholate, 0.1% SDS, 120 mM NaCl, 50 mM Tris-HCl (pH 7.7); (ii) 150 mM NaCI, 5 mM EDTA, 1% Triton X-100, 50 mM Tris-HCI (pH 7.4); (iii) 150 mM NaCI, 5 mM EDTA, 50 mM Tris-HCl (pH 7.4); (iv) 0.5 M LiCl, 100 mM Tris-HCI (pH 7.6); and (v) H20. Pellets were finally resuspended in SDS-PAGE sample buffer (62.5 mM Tris-HCI, pH 8.0, 2% SDS, 5% 3-mercaptoethanol, 10% glycerol) and boiled for 6 min. After separation on a 19% SDS-polyacrylamide/6 M urea gel, protein bands were identified by fluorography.
Mitogenicity assay PB-3c or FDC-P1 cells were washed three times in IMDM, containing 10% fetal calf serum, and 2 x 104 cells were incubated with 10-20 1l of appropriate dilutions of conditioned medium for 18-24 h at 37°C in 96-well microtiter plates in a total volume of 120 ll. After addition of 0.5 tsCi of [3H]thymidine (87 Ci/mol, Amersham) per well, cells were incubated for an additional 6 h at 37°C before radioactive incorporation was determined by standard procedures.
Antibody inhibition
Twenty microliters of conditioned medium were pre-incubated with 10 /l of either rabbit anti-GM-CSF antibody preparation (30 jig/ml), or control rabbit anti-mouse immunoglobulin (100 Ag/ml) for 2 h at 37°C in a total volume of 70 Al of medium. FDC-P1 cells were washed and resuspended in IMDM with 10% fetal calf serum and distributed into the microtiter wells at 2 x 104 cells/50 Al. After a 24-h incubation at 37°C, incorporation of [3H]thymidine was determined as described.
Solution hybridization and RNase protection assay
Transcription of the linearized SP6 GM-CSF construct and RNase protection analysis were carried out according to Melton et al., (1984) . Antisense RNA was generated from the SP6 promoter within the vector which carries a 400-bp fragment of the mouse GM-CSF coding region. Prior to in vitro transcription, the DNA template was linearized with the BamHI restriction endonuclease, which cuts 449 bp downstream from the SP6 promoter. Thus, transcription by SP6 polymerase generated RNA transcripts with a length of 449 bases. This labeled RNA probe was added to the RNA samples and after denaturation at 90°C for 5 min the mixture was incubated for 16 h at 46°C. After digestion of single-stranded RNA with RNases A and TI, the protected fragments were separated on a 6% polyacrylamide/8 M urea gel and visualized by autoradiography. RNase protection assay for IL-3-specific mRNA was carried out using a 32P-labeled antisense RNA generated from pSP6-multi-CSF which carries a 368-bp fragment of the IL-3 coding region. The RNA transcripts generated by SP6 polymerase were 395 bp long.
